Entelos, Inc. Enters Research Deal with UCB Pharma in Rheumatoid Arthritis

LONDON (Thomson Financial) - Entelos Inc said it has signed a research deal with UCB Pharma S A to conduct in silico research in the field of rheumatoid arthritis using the Entelos Rheumatoid Arthritis PhysioLab platform.
MORE ON THIS TOPIC